Followers | 324 |
Posts | 22331 |
Boards Moderated | 0 |
Alias Born | 03/13/2014 |
Wednesday, June 29, 2022 12:20:36 PM
$CMGR
— OTC Updates (@OtcUpdates) June 29, 2022
💰0.0080
Pink Current, AS: 8.0B, OS: 314M
Outstanding Shares Updated:
🔴 173,631,936 (2022-06-02)
🟢 314,348,829 (2022-06-29)
Difference: +81.0% (+140M)
Authorized Shares Updated:
🔴 2,000,000...
Full Details: https://t.co/U6nM8zjejy
Recent CMGR News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 02:37:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 02:35:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 02:34:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 02:32:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 02:29:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 02:25:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 02:23:59 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 02:22:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 01:30:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:15:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 01:00:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 01:00:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 12:30:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2023 09:36:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2023 12:30:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 12:30:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 12:35:21 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM